GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hunan Haili Chemical Industry Co 600731.SS · CNY

Materials · Shanghai · 🇨🇳 China

Compare

5.52

-0.18%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.81bn

FY2016FY2025

Net income

CN¥243.6m

FY2016FY2025

Free cash flow

CN¥17.1m

FY2016FY2025

Shareholders' equity

CN¥3.17bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥1.81bnCN¥2.47bnCN¥2.37bnCN¥3.13bnCN¥2.75bnCN¥2.18bnCN¥2.15bnCN¥1.63bnCN¥1.04bnCN¥904.4m
Gross profitCN¥601.6mCN¥640.5mCN¥530.1mCN¥786.5mCN¥625.7mCN¥656.9mCN¥584.1mCN¥455.5mCN¥329.7mCN¥282.2m
Research and developmentCN¥146.6mCN¥27.6mCN¥40.6mCN¥145.9mCN¥104.5mCN¥83.4mCN¥86.8mCN¥44.4mCN¥39.6mCN¥17.8m
Operating incomeCN¥244.7mCN¥328.2mCN¥292.7mCN¥428.0mCN¥323.2mCN¥364.7mCN¥171.0mCN¥189.9mCN¥73.5mCN¥86.6m
Net incomeCN¥243.6mCN¥265.4mCN¥273.8mCN¥352.3mCN¥266.7mCN¥296.4mCN¥101.1mCN¥51.5mCN¥41.7mCN¥14.2m
Diluted earnings per share0.440.470.490.76-16,772.258.35-779.9620.67269.6511.56

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥4.65bnCN¥4.59bnCN¥4.40bnCN¥3.93bnCN¥3.25bnCN¥2.97bnCN¥2.41bnCN¥2.25bnCN¥1.88bnCN¥1.82bn
Cash and short-term investments—CN¥1.08bnCN¥1.06bnCN¥769.3mCN¥471.2mCN¥889.2mCN¥503.9mCN¥453.6mCN¥269.5mCN¥136.8m
Total liabilitiesCN¥1.34bnCN¥1.32bnCN¥1.26bnCN¥1.73bnCN¥1.36bnCN¥1.40bnCN¥1.14bnCN¥1.08bnCN¥988.7mCN¥981.6m
DebtCN¥495.3mCN¥431.8mCN¥446.5mCN¥717.8mCN¥339.0mCN¥602.6mCN¥427.5mCN¥452.9mCN¥455.0mCN¥477.5m
Shareholders' equityCN¥3.17bnCN¥3.16bnCN¥3.00bnCN¥2.05bnCN¥1.71bnCN¥1.46bnCN¥1.17bnCN¥1.07bnCN¥809.5mCN¥765.9m
Shares outstanding556m559m559m462m—36m—2m0m1m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥246.8mCN¥371.1mCN¥409.9mCN¥249.1mCN¥121.9mCN¥459.1mCN¥200.4mCN¥116.0mCN¥160.6mCN¥136.1m
Capital spending−CN¥229.7m−CN¥216.8m−CN¥383.2m−CN¥321.1m−CN¥184.6m−CN¥263.1m−CN¥98.2m−CN¥87.1m−CN¥70.5m−CN¥85.7m
Free cash flowCN¥17.1mCN¥154.3mCN¥26.6m−CN¥72.0m−CN¥62.7mCN¥195.9mCN¥102.2mCN¥28.9mCN¥90.1mCN¥50.4m
Dividends paid−CN¥124.9m−CN¥127.4m−CN¥21.3m−CN¥16.8m−CN¥85.3m−CN¥16.2m−CN¥38.1m−CN¥27.8m−CN¥33.6m−CN¥30.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥481.7mCN¥438.7mCN¥414.4mCN¥513.4mCN¥534.6mCN¥431.1mCN¥763.5mCN¥666.7m
Gross profitCN¥136.8mCN¥126.1mCN¥173.8mCN¥142.6mCN¥153.4mCN¥131.8mCN¥221.3mCN¥192.8m
Operating incomeCN¥50.1mCN¥55.5mCN¥60.2mCN¥67.4mCN¥106.8mCN¥70.2mCN¥102.7mCN¥107.2m
Net incomeCN¥34.3mCN¥44.6mCN¥45.5mCN¥54.7mCN¥86.8mCN¥56.6mCN¥64.8mCN¥99.5m
Diluted earnings per share0.060.080.080.100.160.100.120.18
Cash from operations———CN¥86.0mCN¥95.0m−CN¥62.0m——
Capital spending−CN¥13.0m−CN¥12.0m−CN¥41.0m−CN¥33.0m−CN¥24.0m−CN¥130.0m−CN¥75.0m−CN¥43.0m
Free cash flow———CN¥53.0mCN¥71.0m−CN¥192.0m——
Total assetsCN¥4.54bnCN¥4.52bnCN¥4.65bnCN¥4.46bnCN¥4.67bnCN¥4.47bnCN¥4.59bnCN¥4.40bn
Cash and short-term investments———CN¥892.2mCN¥1.03bnCN¥877.1mCN¥1.08bnCN¥919.0m
DebtCN¥474.6mCN¥476.4mCN¥495.3mCN¥64.9mCN¥489.0mCN¥447.6mCN¥430.5mCN¥443.0m
Shareholders' equityCN¥3.26bnCN¥3.22bnCN¥3.17bnCN¥3.17bnCN¥3.31bnCN¥3.22bnCN¥3.16bnCN¥3.09bn

Financial ratios

Data as of 19 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin33.2%25.9%22.3%25.1%22.8%30.1%
Operating margin17.5%13.7%13.4%14.3%12.7%17.7%
Net margin13.5%10.7%11.5%11.3%9.7%13.6%
Return on equity7.7%8.4%9.1%17.2%15.6%20.2%
Return on assets5.2%5.8%6.2%9.0%8.2%10.0%
Free cash flow yield14.8%18.1%24.5%21.3%-332415.9%350.6%
Revenue growth-26.7%4.1%-24.1%13.9%25.9%1.5%
Earnings growth-8.2%-3.1%-22.3%32.1%-10.0%193.2%
Current ratio3.36x3.34x3.30x2.49x2.05x2.16x
Debt to equity0.16x0.14x0.15x0.35x0.23x0.46x
Equity ratio68.2%68.9%68.3%52.1%52.7%49.3%
Interest coverage26.22x29.33x25.51x24.51x19.95x17.58x
R&D as a share of sales8.1%1.1%1.7%4.7%3.8%3.8%
Buybacks as a share of market value0.4%-0.0%-21.0%2905106.3%100.0%27500.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-16.7%-3.7%5.5%
Operating income-17.0%-7.7%24.1%
Net income-11.6%-3.8%33.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin29.0%26.1%26.1%26.7%
Operating margin13.4%13.2%13.5%11.8%
Net margin11.9%11.6%11.5%8.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings15.512.013.49.80.8-0.00.20.00.7283.7
Price to sales2.11.31.61.10.1———0.03.7

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 4 Jul 2025.

FY2025FY2024FY2021FY2005FY2003FY2002FY2001
Paid in the year0.200.200.0360.0110.0110.0110.028
  • 6-for-5 split · 25 May 2021
  • 1-to-1 reverse split · 10 Mar 2006
  • 1.51-for-1 split · 24 Oct 2000
  • 13-for-10 split · 4 Jun 1998
  • 3-for-2 split · 3 Jul 1997
  • 13-for-10 split · 27 Dec 1996

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.